会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Process for producing cold-rolled high strength steel sheet having
excellent formability and conversion-treatability
    • 具有优异的成形性和转化处理性的冷轧高强度钢板的制造方法
    • US4956025A
    • 1990-09-11
    • US292120
    • 1988-12-30
    • Kazuo KoyamaTaketoshi TairaKaoru KawasakiAtsushi ItamiNobuhiko Matsuzu
    • Kazuo KoyamaTaketoshi TairaKaoru KawasakiAtsushi ItamiNobuhiko Matsuzu
    • C21D9/46C21D8/02C21D8/04C21D9/56C22C38/00C22C38/14C23C22/78
    • C21D8/0426C21D8/0436C21D8/0473
    • A process for producing a cold-rolled high strength steel sheet having an excellent formability and conversion-treatability, comprising the steps of: heating to a temperature of 1150.degree. C. or lower, a steel slab comprising; 0.005 wt % or less of C, 0.5-1.5 wt % of Si, 0.1-0.5 wt % of Mn, 0.003-0.05 wt % and at least 3.4.times.N wt % of Ti, 0.003-0.05 wt % and at least 7.8.times.C wt % of Nb, 0.01-0.1 wt % of Al, 0.05-0.15 wt % of P, 0.010 wt % or less of S, 0.005 wt % or less of N, 0.0001-0.0050 wt % of B, the balance consisting of Fe and unavoidable impurities; hot-rolling the steel slab with a finishing rolling temperature of the A.sub.r3 point of the steel or higher to obtain a hot-rolled steel sheet; cooling the hot-rolled steel sheet at a cooling rate of 10.degree. C./sec or more in the stage between said finishing rolling and the following coiling step, with the provision that said cooling is started not later than 2 sec after the hot-rolling is finished and is continued for a duration of at least 3 sec; coiling the steel sheet at a temperature of 650.degree. C. or higher; cold-rolling the steel sheet at a usual rolling draft; and continuous-annealing the cold-rolled steel sheet at a heat-cycle of holding for 1 sec or longer at a temperature of 930.degree. C. or lower to complete the recrystallization of the cold-rolled steel sheet.
    • 一种制造具有优异的成形性和转化处理性的冷轧高强度钢板的方法,包括以下步骤:加热至1150℃或更低的温度,包括: 0.005重量%以下的C,0.5-1.5重量%的Si,0.1-0.5重量%的Mn,0.003-0.05重量%和至少3.4×N重量%的Ti,0.003-0.05重量%和至少7.8重量% 的Nb,0.01〜0.1重量%的Al,0.05〜0.15重量%的P,0.010重量%以下的S,0.005重量%以下的N,0.0001-0.0050重​​量%的B,余量由Fe和 不可避免的杂质; 以钢的Ar3点的精轧温度对钢坯进行热轧或更高的热轧,得到热轧钢板; 在所述精轧和后续卷取步骤之间的阶段以10℃/秒以上的冷却速度冷却热轧钢板,其条件是所述冷却不迟于热轧后的2秒开始, 轧制完成并持续至少3秒的持续时间; 在650℃以上的温度下卷取钢板; 以通常的轧制条件对钢板进行冷轧; 在930℃以下的温度下保持1秒以上的热循环,对冷轧钢板进行连续退火,完成冷轧钢板的再结晶。
    • 6. 发明授权
    • Amplifier circuit
    • 放大器电路
    • US08766715B2
    • 2014-07-01
    • US13511233
    • 2011-08-29
    • Kazuo Koyama
    • Kazuo Koyama
    • H03F3/45
    • H03F3/45475H03F3/3022H03F3/45183H03F3/45928H03F2203/45082H03F2203/45528
    • An amplifier circuit capable of reducing load of a circuit at the previous stage by providing increased input impedance producing less noises. The amplifier circuit includes a fully-differential operational amplifier composed of an inverting input terminal, a non-inverting input terminal receiving a signal different from a signal to be input to the inverting input terminal, an inverting output terminal with the same polarity of the inverting input terminal, and a non-inverting output terminal with reverse polarity; an input impedance element with one end connected to the inverting input terminal; an input impedance element with one end connected to the non-inverting input terminal; and positive feedback impedance elements, with one end of connected to the other end of the input impedance element and the other end connected to the inverting output terminal or to the non-inverting output terminal.
    • 一种放大器电路,其能够通过提供增加的输入阻抗产生较少的噪声来减小前一电路的负载。 放大器电路包括由反相输入端子,非反相输入端子接收与要输入到反相输入端子的信号不同的信号的全差分运算放大器,反相输出端子具有与反相输入端子相同极性的反相输出端子 输入端子和反相输出端子; 输入阻抗元件,其一端连接到反相输入端子; 输入阻抗元件,其一端连接到非反相输入端子; 和正反馈阻抗元件,其一端连接到输入阻抗元件的另一端,另一端连接到反相输出端或非反相输出端。
    • 9. 发明授权
    • Benzylamine analogues
    • 苄胺类似物
    • US07514475B2
    • 2009-04-07
    • US11583499
    • 2006-10-19
    • Kazuo KoyamaShinji MarumotoNarihiro TodaHiroshi KogenKeiko Suzuki
    • Kazuo KoyamaShinji MarumotoNarihiro TodaHiroshi KogenKeiko Suzuki
    • A61K31/137C07C205/04
    • C07C219/30C07C271/44C07C323/20C07C323/25C07C333/04C07D213/64C07D213/68C07D215/20C07D317/58C07D333/38
    • A compound of the formula (I): wherein R1 is a C1-C6 alkyl, an amino, a (C1-C6 alkyl)amino, a di(C1-C6 alkyl)amino or a nitrogen-containing saturated heterocyclic; R2 and R3 are the same or different and are a hydrogen or a C1-C6 alkyl; Arom is an unsubstituted or substituted aryl or an unsubstituted or substituted heteroaryl; wherein the substituted aryl is substituted at 1 to 5 positions and the substituted heteroaryl is substituted at 1 to 3 positions; wherein the heteroaryl is furyl, thiolyl, pyrrolyl, azepinyl, pyrazolyl, imidazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, 1,2,3 oxadiazolyl, pyranyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl or quinolyl; and wherein the substituents of the substituted aryl and of the substituted heteroaryl are independently halogen, C1-C6 alkyl, halogeno C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylthio, C1-C3 alkylenedioxy, C1-C7 alkanoyl, C2-C7 alkyloxycarbonyl, amino, C1-C7 alkanoylamino, hydroxyl, mercapto, cyano, nitro or carboxyl; A is an ethylene or propylene; Ra is a hydrogen, a C1-C6 alkyl or a C2-C6 alkenyl; E is a single bond, an oxygen, a sulfur or —NR4—, wherein R4 is a hydrogen or a C1-C7 alkanoyl; X1 and X2 are the same or different and are an oxygen or a sulfur, or a pharmacologically acceptable salt or ester thereof.
    • 式(I)的化合物:其中R1是C1-C6烷基,氨基,(C1-C6烷基)氨基,二(C1-C6烷基)氨基或含氮饱和杂环; R2和R3相同或不同,为氢或C1-C6烷基; Arom是未取代或取代的芳基或未取代或取代的杂芳基; 其中取代的芳基在1至5个位置被取代,并且取代的杂芳基在1至3个位置被取代; 吡唑基,咪唑基,恶唑基,异恶唑基,噻唑基,异噻唑基,1,2,3-恶二唑基,吡喃基,吡啶基,哒嗪基,嘧啶基,吡嗪基或喹啉基;其中杂芳基为呋喃基,噻吩基,吡咯基, 并且其中取代的芳基和取代的杂芳基的取代基独立地为卤素,C 1 -C 6烷基,卤代C 1 -C 6烷基,C 1 -C 6烷氧基,C 1 -C 6烷硫基,C 1 -C 3亚烷基二氧基,C 1 -C 7烷酰基, C7烷氧基羰基,氨基,C1-C7烷酰基氨基,羟基,巯基,氰基,硝基或羧基; A是乙烯或丙烯; R a是氢,C 1 -C 6烷基或C 2 -C 6烯基; E是单键,氧,硫或-NR4-,其中R4是氢或C1-C7烷酰基; X1和X2相同或不同,为氧或硫,或其药理学上可接受的盐或酯。